Search research articles
Contact Us
Filters
Showing results (31-40 of 148) with videos related to
Page
of 15
Sort By:
Brain Research
|
March 22, 2012
Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands
Maho Kinoshita, Yoshikazu Matsuoka, Takeshi Suzuki, et al.
Analytical Chemistry
|
January 5, 2016
Selection of Color-Changing and Intensity-Increasing Fluorogenic Probe as Protein-Specific Indicator Obtained via the 10BASE(d)-T
Masumi Taki, Hiroaki Inoue, Kazuto Mochizuki, et al.
Clinical Nephrology
|
June 25, 2015
Coagulopathy and spontaneous hemorrhage in a patient with nephrotic syndrome
Wihib Gebregeorgis, Unnikrishnan Pillai, Hirva Mamdani, et al.
Circulation. Cardiovascular Genetics
|
September 4, 2012
Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm
Tyler Duellman, Christopher L Warren, Peggy Peissig, et al.
Laboratory Animals
|
March 30, 2025
Seasonality of the estrus cycle in laboratory mice under constant conditions
Tess M Reichard, Caitlin H Miller, Jay Yang, et al.
The Journal of Physiology
|
June 16, 2007
Propofol inhibits HCN1 pacemaker channels by selective association with the closed states of the membrane embedded channel core
Alex K Lyashchenko, Kacy J Redd, Jay Yang, et al.
Neuroscience Letters
|
September 22, 2009
The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor
Bon Nyeo Koo, Mi Kyeong Kim, Jay Yang, et al.
Plos One
|
August 23, 2012
BLM and RMI1 alleviate RPA inhibition of TopoIIIα decatenase activity
Jay Yang, Csanad Z Bachrati, Ian D Hickson, et al.
DNA Repair
|
December 6, 2005
Suppression of genomic instability by SLX5 and SLX8 in Saccharomyces cerevisiae
Chaoying Zhang, Tania M Roberts, Jay Yang, et al.
Advances in Therapy
|
February 14, 2022
A Matching-Adjusted Indirect Comparison of Single-Arm Trials in Patients with Relapsed or Refractory Follicular Lymphoma Who Received at Least Two Prior Systemic Treatments: Tazemetostat was Associated with a Lower Risk for Safety Outcomes Versus the PI3-Kinase Inhibitors Idelalisib, Duvelisib, Copanlisib, and Umbralisib
David Proudman, Dave Nellesen, Deepshekhar Gupta, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 148) with videos related to
Sort By:
Page
of 15
Brain Research
|
March 22, 2012
Sigma-1 receptor alters the kinetics of Kv1.3 voltage gated potassium channels but not the sensitivity to receptor ligands
Maho Kinoshita, Yoshikazu Matsuoka, Takeshi Suzuki, et al.
Analytical Chemistry
|
January 5, 2016
Selection of Color-Changing and Intensity-Increasing Fluorogenic Probe as Protein-Specific Indicator Obtained via the 10BASE(d)-T
Masumi Taki, Hiroaki Inoue, Kazuto Mochizuki, et al.
Clinical Nephrology
|
June 25, 2015
Coagulopathy and spontaneous hemorrhage in a patient with nephrotic syndrome
Wihib Gebregeorgis, Unnikrishnan Pillai, Hirva Mamdani, et al.
Circulation. Cardiovascular Genetics
|
September 4, 2012
Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm
Tyler Duellman, Christopher L Warren, Peggy Peissig, et al.
Laboratory Animals
|
March 30, 2025
Seasonality of the estrus cycle in laboratory mice under constant conditions
Tess M Reichard, Caitlin H Miller, Jay Yang, et al.
The Journal of Physiology
|
June 16, 2007
Propofol inhibits HCN1 pacemaker channels by selective association with the closed states of the membrane embedded channel core
Alex K Lyashchenko, Kacy J Redd, Jay Yang, et al.
Neuroscience Letters
|
September 22, 2009
The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor
Bon Nyeo Koo, Mi Kyeong Kim, Jay Yang, et al.
Plos One
|
August 23, 2012
BLM and RMI1 alleviate RPA inhibition of TopoIIIα decatenase activity
Jay Yang, Csanad Z Bachrati, Ian D Hickson, et al.
DNA Repair
|
December 6, 2005
Suppression of genomic instability by SLX5 and SLX8 in Saccharomyces cerevisiae
Chaoying Zhang, Tania M Roberts, Jay Yang, et al.
Advances in Therapy
|
February 14, 2022
A Matching-Adjusted Indirect Comparison of Single-Arm Trials in Patients with Relapsed or Refractory Follicular Lymphoma Who Received at Least Two Prior Systemic Treatments: Tazemetostat was Associated with a Lower Risk for Safety Outcomes Versus the PI3-Kinase Inhibitors Idelalisib, Duvelisib, Copanlisib, and Umbralisib
David Proudman, Dave Nellesen, Deepshekhar Gupta, et al.
Page
of 15